Cancer killer cell group has two shots at success
The Irish Times – View full story
ONK closes $21.5 million series A for cord blood-derived NK cell therapy
BioWorld – View full story (behind paywall)
Galway cancer killer cell group ONK raises €19 million
The Irish Times – View full story
Galway’s ONK Therapeutics raises $21.5 million for cancer therapy platform
Silicon Republic – View full story
ONK Therapeutics engineers a seat at the NK cell therapy table
BioWorld – View full story (behind paywall)
Natural killer cells company teams up with TCD
The Irish Times – View full story
From Galway to San Diego: ONK Therapeutics’ Aim to Usher in A New Era of Engineered NK Cell Therapies with the Goal to Ultimately Cure Cancer
JLabs – View full story
ONK inks deal for novel NK cell technology
The PharmaLetter – View full story
